Valuation: Alkem Laboratories Limited

Market Cap 661B 6.93B 6B 5.62B 5.13B 9.65B 9.81B 65.91B 25.83B 331B 26.02B 25.45B 1,104B P/E 2027 *
28.3x
P/E 2028 * 24.6x
Enterprise Value 639B 6.7B 5.81B 5.44B 4.96B 9.33B 9.49B 63.75B 24.98B 320B 25.16B 24.61B 1,067B EV / Sales 2027 *
3.87x
EV / Sales 2028 * 3.44x
Free-Float
37.56%
Yield 2027 *
0.93%
Yield 2028 * 1.02%
1 day-1.02%
1 week-3.69%
Current month-5.19%
1 month-2.17%
3 months-0.86%
6 months-6.90%
Current year-0.93%
1 week 5,420
Extreme 5420
5,696.95
1 month 5,420
Extreme 5420
5,875.8
Current year 5,085
Extreme 5085
5,933
1 year 5,085
Extreme 5085
5,933
3 years 3,440.05
Extreme 3440.05
6,440
5 years 2,835
Extreme 2835
6,440
10 years 1,400
Extreme 1400
6,440
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 31/01/2024
Director TitleAgeSince
Director/Board Member 44 08/08/2013
Director/Board Member 63 10/02/2008
Director/Board Member 45 10/11/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%-3.69% - - 6.93B
-1.37%+8.90%+91.28%+130.00% 1,083B
-0.77%+1.91%+49.46%+49.44% 626B
+0.85%+2.58%+25.90%+64.34% 442B
-1.57%-0.52%+47.24%+36.98% 363B
-1.60%-0.48%+28.71%+36.23% 295B
-1.08%-2.81%+5.52%+5.25% 248B
-0.70%+6.23%+45.32%+57.82% 224B
-3.16%+1.12%-7.15%-51.95% 210B
+2.04%+0.38%+12.70%+69.71% 168B
Average -0.85%+1,662.85%+33.22%+44.20% 406.57B
Weighted average by Cap. -0.93%+1,332.62%+48.93%+65.42%

Financials

2027 *2028 *
Net sales 165B 1.73B 1.5B 1.41B 1.28B 2.42B 2.46B 16.49B 6.46B 82.77B 6.51B 6.37B 276B 182B 1.91B 1.66B 1.55B 1.41B 2.66B 2.71B 18.17B 7.12B 91.18B 7.17B 7.01B 304B
Net income 23.59B 247M 214M 201M 183M 345M 350M 2.35B 922M 11.81B 929M 908M 39.39B 27.38B 287M 249M 233M 212M 400M 407M 2.73B 1.07B 13.7B 1.08B 1.05B 45.72B
Net Debt -21.73B -228M -197M -185M -169M -317M -323M -2.17B -849M -10.88B -856M -837M -36.29B -35.11B -368M -319M -299M -272M -513M -521M -3.5B -1.37B -17.57B -1.38B -1.35B -58.63B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
12/08/26 5,454.00 -1.02% 1,803
11/08/26 ₹5,510.00 -0.47% 2,366
10/08/26 ₹5,536.05 -1.68% 2,639
07/08/26 ₹5,630.55 +0.39% 2,854
06/08/26 ₹5,608.45 -0.96% 1,518
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,527.50INR
Average target price
5,964.80INR
Spread / Average Target
+7.91%

Quarterly revenue - Rate of surprise